NDA 018227 · Hospira
Amidate
Etomidate · Injection · General Anesthetic
NovelLast checked: Nov 20, 2026Latest source record: Apr 27, 2017 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1982
Sep 7, 1982
Approved uses
1
Original approval plus efficacy supplements
Registered trials
114
8 Phase 3, 10 recruiting
FAERS reports
2,262
2,079 serious, 478 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Oct 22, 2026.
INDICATIONS AND USAGE AMIDATE is indicated by intravenous injection for the induction of general anesthesia. When considering use of AMIDATE, the usefulness of its hemodynamic properties (see CLINICAL PHARMACOLOGY ) should be weighed against the high frequency of transient skeletal muscle movements (see ADVERSE REACTIONS ). Intravenous AMIDATE is also indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization.
Therapeutic areas: Pain and anesthesia
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Sep 7, 1982 Original approval · Type 1 - New Molecular Entity
1 products under this application
- AMIDATE · ETOMIDATE 2MG/ML · INJECTABLE, INJECTION · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Etomidate" as an intervention, any sponsor and status, largest first.
- The GUARDIAN Trial - Induction Agent Sub-StudyPivotal-lookingEnrolling by invitation
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT04934683 · 6,254 participants (planned) · Start Jul 25, 2021 · Primary completion Dec 31, 2026
Drug: Etomidate Induction; Propofol Induction · For: Major Surgery
Sites: Omaha, Nebraska; Cleveland, Ohio; Shanghai, China · 11 sites in all
- Anesthesia and Non-small Cell Lung Cancer RecurrencePivotal-lookingRecruiting
Samsung Medical CenterAcademic, hospital or other
NCT06330038 · 5,384 participants (planned) · Start Aug 5, 2024 · Primary completion Dec 31, 2028
Drug: Propofol; Inhaled anesthetics · For: Non-small Cell Lung Cancer; Surgery; Anesthesia
Sites: Seoul, South Korea
- Combined Use of Etomidate and Propofol in Painless Gastroscopy.Pivotal-lookingStatus unknown
Jiangsu Nhwa Pharmaceutical Co., Ltd.Industry
NCT01913054 · 2,450 participants (planned) · Start Aug 2013 · Primary completion Dec 2013
Drug: Fentanyl Injection; Etomidate Fat Emulsion Injection and 1 more · For: Safety of Gastroscopy
Sites: Beijing, China; Harbin, China; Wuhan, China · 6 sites in all
- Randomized Trial of Sedative Choice for IntubationPivotal-lookingCompleted
Vanderbilt University Medical CenterAcademic, hospital or other
NCT05277896 · 2,367 participants · Start Apr 6, 2022 · Primary completion Sep 6, 2025
Drug: Ketamine; Etomidate · For: Acute Respiratory Failure
Sites: Birmingham, Alabama; Aurora, Colorado; Denver, Colorado · 6 sites in all
- Etomidate to Improve Outcome in Elderly PatientsPivotal-lookingCompleted
Zhihong LUAcademic, hospital or other
NCT02910206 · 1,917 participants · Start Aug 15, 2017 · Primary completion Nov 20, 2019
Drug: Etomidate; propofol and 2 more · For: Postoperative Complications
Sites: Xi'an, China
- Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal SurgeryPivotal-lookingStatus unknown
Second Affiliated Hospital of Nanchang UniversityAcademic, hospital or other
NCT05624424 · 1,317 participants (planned) · Start Nov 15, 2022 · Primary completion Oct 31, 2023
Drug: Rematazolam Besylate; Propofol and 4 more · For: Emergence Agitation; Remimazolam Besylate; Perioperative Sedation and 2 more
Sites: Ganzhou, China; Jiujiang, China; Nanchang, China · 6 sites in all
- Safety and Efficacy of Maintenance of Etomidate in General AnesthesiaPivotal-lookingCompleted
Henan Provincial People's HospitalAcademic, hospital or other
NCT05223907 · 1,080 participants · Start May 1, 2021 · Primary completion Dec 31, 2022
Drug: Etomidate; Propofol · For: General Anesthesia
Sites: Zhengzhou, China
- Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical TrialPivotal-lookingCompleted
University of Texas Southwestern Medical CenterAcademic, hospital or other
NCT02643381 · 801 participants · Start Jun 6, 2016 · Primary completion Dec 1, 2020
Drug: Etomidate; Ketamine · For: Cardiopulmonary Arrest; Respiratory Arrest
Sites: Dallas, Texas
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- renal failure239
- pain205
- injury186
- anxiety181
- drug ineffective175
- unevaluable event168
- hypotension159
- fear154
- cardiac arrest148
- emotional distress144
- renal injury134
- renal impairment127
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 60 |
| 2005 | 28 |
| 2006 | 39 |
| 2007 | 32 |
| 2008 | 47 |
| 2009 | 42 |
| 2010 | 72 |
| 2011 | 214 |
| 2012 | 103 |
| 2013 | 60 |
| 2014 | 78 |
| 2015 | 76 |
| 2016 | 96 |
| 2017 | 84 |
| 2018 | 106 |
| 2019 | 87 |
| 2020 | 166 |
| 2021 | 129 |
| 2022 | 123 |
| 2023 | 152 |
| 2024 | 117 |
| 2025 | 195 |
| 2026 | 156 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Current · updated Nov 9, 2026
Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01). Other
Current · updated Nov 9, 2026
Amidate, Injection, 2 mg/mL (NDC 0409-6695-02).
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Ketamine Versus Etomidate for Rapid Sequence Intubation: A Systematic Review and Meta-Analysis of Randomized Trials.
Greer A, Hewitt M, Khazaneh PT, et al. · Crit Care Med 2025 · Systematic Review, Meta-Analysis
- Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults.
Casey JD, Seitz KP, Driver BE, et al. · N Engl J Med 2026 · Clinical Trial, Phase IV, Comparative Study
- Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial.
Matchett G, Gasanova I, Riccio CA, et al. · Intensive Care Med 2022 · Randomized Controlled Trial
- Drug-Induced Myoclonus: A Systematic Review.
Rissardo JP, Fornari Caprara AL, Bhal N, et al. · Medicina (Kaunas) 2025 · Systematic Review
- Safety of procedural sedation in emergency department settings among the adult population: a systematic review and meta-analysis of randomized controlled trials.
Khan MT, Khan AR, Rohail S, et al. · Intern Emerg Med 2024 · Systematic Review, Meta-Analysis
- Etomidate versus ketamine for in-hospital rapid sequence intubation: a systematic review and meta-analysis.
Daghmouri MA, Chaouch MA, Noomen M, et al. · Eur J Emerg Med 2025 · Systematic Review, Meta-Analysis
Sponsor: Pfizer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.